Barriers and enablers in the management of tuberculosis treatment in Addis Ababa, Ethiopia: a qualitative study
- Desfechos clÃnicos do tratamento de tuberculose utilizando o esquema bÃ¡sico recomendado pelo MinistÃ©rio da SaÃºde do Brasil com comprimidos em dose fixa combinada na regiÃ£o metropolitana de GoiÃ¢nia. Ferreira, Anna Carolina Galvão; Júnior, José Laerte Rodrigues da Silva; Conde, Marcus Barreto; Rabahi, Marcelo Fouad // Jornal Brasileiro de Pneumologia;ene/feb2013, Vol. 39 Issue 1, p76
Objective: To describe the rates of cure, treatment failure, and treatment abandonment obtained with the basic regimen recommended by the Brazilian National Ministry of Health (rifampin, isoniazid, pyrazinamide, and ethambutol for two months, followed by isoniazid and rifampin for four months)...
- How does my doctor treat TB infection? // Tuberculosis: Getting Healthy, Staying Healthy;Jun2008, Issue 8, p6
The article provides an answer to a question of how physicians treat tuberculosis (TB) infection.
- A waiting room from hell. Sonkar, Madhulika // Asian Pacific Post;10/27/2011, p16
The article focuses on the case of 17-year-old Shehnaz, who has stayed outside the All India Institute of Medical Sciences (AIIMS) in New Delhi, India for 40 days just to be told by doctors that her bone tuberculosis is incurable.
- New tuberculosis tests reduce diagnostic costs. // PharmacoEconomics & Outcomes News;Mar2015, Vol. 724 Issue 1, p20
The article reports that using novel diagnostics for treating tuberculosis would reduce diagnostic costs.
- Patient satisfaction on tuberculosis treatment service and adherence to treatment in public health facilities of Sidama zone, South Ethiopia. Nezenega, Zekariyas Sahile; Michael Gacho, Yohannes H; Tafere, Tadese Ejigu // BMC Health Services Research;2013, Vol. 13 Issue 1, p1
Background: Patient compliance is a key factor in treatment success. Satisfied patients are more likely to utilize health services, comply with medical treatment, and continue with the health care providers. Yet, the national tuberculosis control program failed to address some of these aspects...
- Antimycobacterial Therapy for Tuberculosis. Weichel, Amy S. // American Family Physician;2/1/2000, Vol. 61 Issue 3, p861
Discusses research on antimycobacterial therapy for tuberculosis. Reference to a study by R. E. Van Scoy and C. J. Wilkowske, from the October 1999 issue of the `Mayo Clinic Proceedings'; Increase in incidence of tuberculosis and other mycobacterial infections; Treatment options for...
- How does my doctor treat TB disease? // Tuberculosis: Getting Healthy, Staying Healthy;Jun2008, Issue 8, p12
The article provides an answers to a question of how physicians treat tuberculosis (TB) disease.
- THE PROBLEM OF MULTIDRUG RESISTANT TUBERCULOSIS. Mitrea, Mirela; Bîrluţiu, Victoria; DEAC, M. // Acta Medica Transilvanica;sep2011, Vol. 16 Issue 3, p332
After the 1940s it was believed that tuberculosis (TB) will be eradicated. Nowdays there is a recrudescence of the disease since the '80s, recorded difficulties associated with resistance to therapy, the emergence of multidrug-resistant tuberculosis (MDR TB) and since 2006 the extensive...
- STRAIN IDENTIFICATION AND EVALUATION OF PCR BASED MOLECULAR METHODS FOR SUBTYPING OF MYCOBACTERIUM TUBERCULOSIS CLINICAL ISOLATES. KATHIRVEL, M.; VALLAYYACHARI, K.; THIRUMURUGAN, R.; USHARANI, B.; SAMROT, ANTONY V.; MUTHURAJ, M. // International Journal of Pharma & Bio Sciences;Jan-Mar2014, Vol. 5 Issue 1, p229
Drug susceptibility profile of 53 Mycobacterium tuberculosis clinical isolates was studied by conventional solid and liquid culture methods. Forty three isolates were drug resistant to at least one drug and 10 were susceptible. The strain identification was performed by PCR amplification of...